Active pulmonary TB — RACP Paediatrics MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Start RIPE therapy (rifampicin, isoniazid, pyrazinamide, ethambutol)
Active pulmonary TB in children is treated with standard RIPE therapy: 2 months of rifampicin, isoniazid, pyrazinamide, and ethambutol, followed by 4 months of rifampicin and isoniazid. In children too young for visual acuity testing, ethambutol risk (optic neuritis) must be discussed. TB is notifiable and contact tracing is mandatory.
Reference: Australian Therapeutic Guidelines – 2024 – Antibiotic; RCH Melbourne – 2023 – TB CPG